MonTa Biosciences will be presenting very strong data on our immuno oncology technology with our drug candidate MBS8 at the annual meeting of AACR in Orlando, Florida. Come to learn more about our technology and have a talk on April 17, where MonTas CEO, Simon S Jensen will present these very encouraging data on cancer immunotherapy.
